Brief: Brii Biosciences Says On July 30, VBI Vaccines Initiated Restructuring Proceedings
31/07/2024 01:59
July 31 (Reuters) - Brii Biosciences Ltd 2137.HK :
* ON JULY 30, VBI VACCINES INITIATED RESTRUCTURING
PROCEEDINGS
* DOES NOT EXPECT MATERIAL IMPACTS ON ITS BUSINESS OPERATION
AND
FINANCIAL PERFORMANCE DUE TO VBI'S INSOLVENCY
Further company coverage: 2137.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR